Navigation Links
Astellas Appoints Shontelle Dodson to Lead Medical Excellence Function
Date:4/6/2015

TOKYO, April 6, 2015 /PRNewswire/ -- Astellas ("Astellas,") (Tokyo: 4503) today announced that Dr. Shontelle Dodson has been named vice president, Medical Excellence, Medical Affairs. Dodson will be located at Astellas' global headquarters for its Medical and Development functions in Northbrook, Ill., USA, and will report to Dr. Charlotte Kremer, executive vice president, Medical Affairs.

Dodson will oversee the Medical Excellence functions within the company's Medical Affairs organization, including Global Medical Communications, Scientific Publications, Health Economics and Outcomes Research, and Medical Affairs Research and Grants. As a key direct report to Kremer, she will play an instrumental role in leading key functional groups that provide support and service across the therapeutic areas served by the company's Medical Affairs organization.

"Astellas couldn't be more pleased to have someone like Shontelle take on this important role in building a best in class Medical Affairs organization," said Kremer. "Her diverse experience across the different facets of medical affairs in industry roles and prior work in clinical settings will offer the insights needed to help Astellas continue to address the unmet needs of our patients."

Dodson joined Astellas in 2012 and, since that time, has led the Health Economics and Clinical Outcomes Research team in the Americas. Under her leadership, that team has pioneered multiple real world data projects, including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations. Dodson holds a doctorate in pharmacy from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tennessee.

About Astellas Pharma Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. Astellas has approximately 18,000 employees worldwide. The organization is committed to becoming a global category leader in Urology, Immunology (including Transplantation) and Infectious diseases, Oncology, Neuroscience and Diabetes Mellitus (DM) Complications and Kidney diseases. For more information on Astellas Pharma Inc., please visit the company website at www.astellas.com/en.

Logo - http://photos.prnewswire.com/prnh/20140416/84970

 


'/>"/>
SOURCE Astellas Pharma Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen
2. Amgen And Astellas Announce Japan Alliance
3. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
4. Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
5. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the AT&T National
6. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
7. Astellas Appoints New Senior Vice President of Global Oncology Development
8. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
9. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
10. Astellas Employees to Change Tomorrow through Annual Day of Service
11. Astellas US Appoints Senior Vice President, Chief Communications Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2019)... ... December 13, 2019 , ... ... Rights of the Child (ARC) ( http://www.arclaw.org ) has today criticized a ... Africa, though only on boys mostly 15 years of age and older. ...
(Date:12/9/2019)... ... December 09, 2019 , ... American ... throughout North America has released its documentary on " Making Data Work: Leveraging ... how pharmaceutical companies are currently using data to produce products, and how they ...
(Date:12/8/2019)... ... December 07, 2019 , ... Soterius, Inc., an outsourced service ... announced that MAIA Pharmaceuticals, Inc. (MAIA), a specialty pharmaceutical company focused on development ... partners in Europe, to support their regulatory strategy and operations for filings in ...
Breaking Medicine Technology:
(Date:12/6/2019)... ... December 06, 2019 , ... C&A ... excellence in employee learning. The Omaha-based company has been named by Training magazine ... successful employer-sponsored training and development programs worldwide. Rankings of the 125 leading companies ...
(Date:12/6/2019)... SALT LAKE CITY (PRWEB) , ... December 06, ... ... “bravery” and “gratitude” were used frequently, six students in Salt Lake Community ... Hanscom, Hevelyn Cidade Klegues, Mark Rodgers and Chelise Schaefer—were awarded the AT&T Public ...
(Date:12/6/2019)... ... 06, 2019 , ... COMPLIANCY GROUP is proud to announce ... Society. Compliancy Group is dedicated to educating and assisting Wyoming Medical Society’s members ... the standards set forth by the Health Insurance Portability and Accountability Act (HIPAA). ...
(Date:12/6/2019)... ... ... Dr. Scott Howell, a 2019 graduate of Trident University International’s (Trident) ... coconut oil in the 7 November 2019 edition of Progress in Cardiovascular Diseases ... Literature Review,” led by Dr. Hector O. Santos, examines the effect of coconut oil ...
(Date:12/5/2019)... (PRWEB) , ... December 05, 2019 , ... ... Practice M&A: Risks and Rewards of Building Platforms— on Thursday, December 12, 2019, ... competing for large, multi-specialty medical groups. Middle-market PE firms are scrambling to assemble ...
Breaking Medicine News(10 mins):